News and Updates

Are 82x ROI claims in oncology trials reality or a trap? Learn why clinical sponsors must look beyond financial metrics to ensure long-term development success.

The EU has revoked authorization for Tavneos (avacopan). Discover why regulators diverged on ANCA-associated vasculitis clinical data and what this means.

New data reveals a persistent gender gap in Structural Heart Disease trial leadership. Learn how this disparity impacts cardiovascular research outcomes.

With over 1,500 AI medical devices cleared by the FDA, experts are questioning if clinical evidence is keeping pace with rapid technological innovation.

Discover how advancements in precision medicine and personalized therapy are helping patients beat "hopeless" diagnoses and achieve unexpected recovery.

Discover the clinical differences between Influenza A and B in pediatric myositis. Learn how to recognize and manage post-flu muscle pain in children.

Haleon and A*STAR partner on a clinical study exploring how multivitamin supplementation improves metabolic health in midlife Asian women. Learn more.

New regulatory initiatives are accelerating clinical trial approvals across Africa, aiming to foster health equity and boost global medical innovation.

OncoC4 begins human trials for ONC-783, a novel T-cell engager targeting specific CD24 glycoforms in solid tumors. Learn more about this new cancer therapy.

A major Phase III trial for a monoclonal antibody combo in advanced colorectal cancer has failed, falling short of primary survival endpoints. Read more.